Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
88.41
-0.09 (-0.10%)
At close: Jun 18, 2026, 4:00 PM EDT
88.74
+0.33 (0.37%)
After-hours: Jun 18, 2026, 7:57 PM EDT

Abbott Laboratories Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
153,994217,579195,872190,870190,793248,277
Market Cap Growth
-33.39%11.08%2.62%0.04%-23.15%28.02%
Enterprise Value
180,835222,210202,267198,494197,615256,300
Last Close Price
88.41125.29113.11110.07109.79140.74
PE Ratio
24.7633.6814.8133.7628.0835.72
Forward PE
15.7922.6322.3924.2226.6430.05
PEG Ratio
1.702.352.612.855.162.38
PS Ratio
3.414.914.674.764.375.76
PB Ratio
2.964.174.114.945.206.93
P/TBV Ratio
-9.7011.0431.5156.41-
P/FCF Ratio
20.8729.4230.8437.7324.4528.71
P/OCF Ratio
16.2722.7522.8926.2919.9123.57
EV/Sales Ratio
4.015.014.824.954.535.95
EV/EBITDA Ratio
15.4019.9020.1420.4216.9921.42
EV/EBIT Ratio
21.0727.5929.6430.6423.6330.42
EV/FCF Ratio
24.5130.0531.8539.2425.3229.64
Debt / Equity Ratio
0.560.190.260.350.390.48
Debt / EBITDA Ratio
3.131.161.411.511.441.51
Debt / FCF Ratio
4.621.752.222.902.152.09
Net Debt / Equity Ratio
0.510.080.130.190.180.22
Net Debt / EBITDA Ratio
2.460.360.610.760.570.65
Net Debt / FCF Ratio
3.630.540.971.460.850.90
Asset Turnover
0.460.530.540.540.580.58
Inventory Turnover
2.933.052.932.823.383.65
Quick Ratio
1.011.181.231.161.231.46
Current Ratio
1.391.581.671.641.631.85
Return on Equity (ROE)
11.90%12.96%30.91%15.11%19.01%20.49%
Return on Assets (ROA)
6.03%7.38%16.87%7.54%9.33%9.82%
Return on Invested Capital (ROIC)
7.57%9.67%22.29%10.37%13.12%13.36%
Return on Capital Employed (ROCE)
9.50%11.72%10.78%10.95%13.82%13.73%
Earnings Yield
4.06%2.97%6.75%2.96%3.56%2.80%
FCF Yield
4.79%3.40%3.24%2.65%4.09%3.48%
Dividend Yield
2.85%1.89%1.95%1.86%1.72%1.28%
Payout Ratio
69.47%63.09%28.62%62.14%47.73%45.28%
Buyback Yield / Dilution
-0.03%0.00%0.06%0.85%1.40%-0.17%
Total Shareholder Return
2.82%1.89%2.01%2.71%3.12%1.11%
SEC Filings: 10-K · 10-Q